Table 3.

Main indications for Liver Transplantation and Five-Year Survival in Adult Patients (Age, ≥19 Years)

Type of Indication	No. of Patients	5-yr Survivors
Chronic aggressive hepatitis	33	7 (21.2%)
Alcoholic cirrhosis	15	3 (20.0%)
Primary liver malignancy*	15	1 (6.7%)
Sclerosing cholangitis	7	0
Primary biliary cirrhosis	6	1 (16.7%)
Alpha-1-antitrypsin deficiency	2	0
Secondary biliary cirrhosis†	2	1 (50.0%)
Hemochromatosis	1	0
Protoporphyria	1	0
Budd-Chiari syndrome	1	1 (100.0%)
Acute hepatitis B	1	0
Total	84	14 (16.7%)

^*Hepatoma, seven; duct cell carcinoma (Klatskin), five; cholangiocarcinoma, one; hemangioendothelial sarcoma, one; and unclassified sarcoma, one.

^†One example each of possible duct hypoplasia and choledochaf cyst. Both patients had had multiple operations.